Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAT2A | P31153 | 9/20 | 0.35 |
| ▸ | LIG1 | P18858 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.34 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.34 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30396737 | 1.00 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL30057522 | 0.90 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL23079964 | 0.90 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL29370392 | 0.89 | L3MBTL1 (0.56) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL181585 | 0.89 | L3MBTL1 (0.56) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL10018678 | 0.88 | L3MBTL1 (0.50) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL38661092 | 0.86 | L3MBTL1 (0.53) | L3MBTL1KDM4EATMRXFP1ALDH1A1 | |
| SCHEMBL16558195 | 0.86 | L3MBTL1 (0.53) | L3MBTL1KDM4EATMRXFP1ALDH1A1 | |
| SCHEMBL26557754 | 0.86 | L3MBTL1 (0.55) | L3MBTL1KDM4EATMCYP2A6RXFP1 | |
| SCHEMBL23079608 | 0.86 | L3MBTL1 (0.54) | L3MBTL1KDM4EATMALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230200101-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200101-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200101-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| CN-115991668-A | Novel compound for coating layer and organic light-emitting element comprising same | 东进世美肯株式会社 | 2023-04-21 | — | — | CN | disclosed |
| WO-2019198934-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 삼성에스디아이 주식회사 | 2019-10-17 | — | — | WO | disclosed |
| EP-3553050-A1 | COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | Samsung SDI Co., Ltd. (KR) | 2019-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230200101-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SLC1A2, MAOA, SLC18A1 | L3MBTL1 118/4885KDM4E 1088/4885ATM 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.